Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 3.62036 | 60 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 4.41014 | 70 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 3.63779 | 61 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 4.48751 | 70 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 4.02856 | 67 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 3.26424 | 49 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 3.7693 | 62 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 3.5281 | 59 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 3.50181 | 58 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 3.52565 | 59 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 3.80743 | 64 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 3.27619 | 53 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 3.85258 | 64 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 3.55893 | 59 |